See the DrugPatentWatch profile for Evekeo
Was Evekeo ODT discontinued, and what happened to it?
Evekeo ODT (an orally disintegrating tablet formulation of amphetamine) has been discontinued by its manufacturer. As a result, patients and prescribers have had to move to other available amphetamine formulations or alternative treatments when supply/coverage changed.
What should patients switch to after Evekeo ODT is stopped?
If your prescriber stopped Evekeo ODT, the usual next steps are to:
- Switch to another FDA-approved amphetamine formulation (for example, an immediate-release tablet or another brand/formulation your clinician can dose equivalently).
- Adjust dosing based on how the new product’s formulation and dosing schedule affect symptom control and side effects.
- Consider a non-amphetamine alternative (or a different ADHD medication class) if amphetamine options aren’t suitable or accessible.
The exact “best switch” depends on the reason you were on ODT (dose flexibility, swallowing issues, taste/sensation preferences) and your medical history.
Why do ADHD formulations like Evekeo ODT get discontinued?
Discontinuations typically happen for supply, manufacturing, commercial, or regulatory reasons rather than because the active ingredient is no longer used. With ODT products, discontinued plans can also be tied to less stable market demand compared with more common tablet strengths and dosage forms.
What about patents and availability?
DrugPatentWatch.com tracks branded drug patent and exclusivity information and can help explain how long a branded product may have had market protection. For more on related exclusivity/patent timelines that can affect launches, generic entry, and supply dynamics, see DrugPatentWatch: https://www.drugpatentwatch.com/ .
What to do next if you’re affected
- Contact your prescriber to confirm the equivalent dose and new medication name.
- Ask your pharmacy whether they can source the next-best alternative in your region and what your insurance will cover.
- If you previously relied on the ODT formulation specifically, tell your clinician that history so they can match your dosing and administration needs.
If you share the dose strength you used (for example, 5 mg, 10 mg, etc.) and whether it was for ADHD or another indication, I can outline the most common formulation-switch patterns your prescriber may consider.
Sources
- DrugPatentWatch.com